Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum

Neuroendocrinology Letters

Volumn 32, Issue 3, 2011, Pages 360-364

  Očadlík, Ivan ^a   Hlinšťáková, Stella ^a   Oravec, Stanislav ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Benign hyperbilirubinemia; Gilbert syndrome; Lipoprotein spectrum; Small dense LDL

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; SMALL DENSE LOW DENSITY LIPOPROTEIN; THYROTROPIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORESIS; FREE THYROXINE INDEX; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GILBERT DISEASE; HUMAN; MOLECULAR GENETICS; PROTEIN ANALYSIS; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 80052000289     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bosma PJ, Chowhudry JR, Bakker C, et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronyltransferase 1 in Gilbert's syndrome. N Engl J Med. 333(18): 1171-5.
2. Djoussé L, Levy D, Cupples LA, et al. (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol. 87(10): 1196-1200; A4,7.
3. Hoefner DM, Hodel SD, O'Brien JF, et al. (2001) Development of a Rapid, Quantitative Method for LDL subfraction with Use of the Quantimetrix Lipoprint LDL System. Clin Chem. 47(2): 266-274.
4. Hopkins PN, Wu LL, Hunt SC, et al. (1996) Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 16(2): 250-255. (Pubitemid 26056243)
5. Lin JP, O'Donnell ChJ, Schwaiger JP, et al. (2006) Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart Study. Circulation. 114(14): 1476-1481.
6. Marilena G (1997) New Physiological Importance of Two Classic Residual Products: Carbon Monoxide and Bilirubin. Biochem Mol Med. 61(2): 136-142.
7. Novotný L, Vítek L (2003) Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies. Exp Biol Med (Maywood). 228(5): 568-571.
8. Oravec S, Dukat A, Gavornik P, Caprnda M, Kucera M, Ocadlik I (2011) Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension. Bratisl Lek Listy. 112(1): 4-7.
9. Schwertner HA, Jackson WG, Tolan G (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 40(1): 18-23. (Pubitemid 24050206)
10. Schwertner HA, Vitek L (2008) Gilbert syndrome, UGTIA1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 198(1): 1-11.
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320(14): 915-924. (Pubitemid 19101597)
12. Stocker R, Keaney JF Jr. (2004) Role of Oxidative Modifications in Atherosclerosis. Physiol Rev. 84(4): 1381-1478.
13. Vítek L, Jirsa M Jr, Brodanová M, et al. (2002) Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 160(2): 449-456. (Pubitemid 34159340)